| Endocrine system | |||||
|---|---|---|---|---|---|
| Endocrine system / Adrenocortical function testing | |||||
| tetracosactide | On Formulary | ||||
| Solution for injection | |||||
| Synacthen (Atnahs Pharma UK Ltd) | On Formulary | ||||
| Suspension for injection | |||||
| Synacthen Depot (Atnahs Pharma UK Ltd) | On Formulary | ||||
| Endocrine system / Assessment of pituitary function | |||||
| gonadorelin | On Formulary | ||||
| Endocrine system / Gonadotrophin replacement therapy | |||||
| choriogonadotropin alfa | Restricted | ||||
| Solution for injection | |||||
| Ovitrelle (Merck Serono Ltd) | Restricted | ||||
| lutropin alfa | Non Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Luveris (Merck Serono Ltd) | Non Formulary | ||||
| Endocrine system / Growth hormone disorders | |||||
| pegvisomant | Non Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Somavert (Pfizer Ltd) | Non Formulary | ||||
| somatropin | Restricted |
NICE TA64 |
|||
| Solution for injection | |||||
| Norditropin FlexPro (Novo Nordisk Ltd) | Restricted | ||||
| Omnitrope SurePal (Sandoz Ltd) | Restricted | ||||
| Saizen (Merck Serono Ltd) | Restricted | ||||
| Powder and solvent for solution for injection | |||||
| Genotropin (Pfizer Ltd) | Restricted | ||||
| Genotropin GoQuick (Pfizer Ltd) | Restricted | ||||
| Genotropin MiniQuick (Pfizer Ltd) | Restricted | ||||
| Zomacton (Ferring Pharmaceuticals Ltd) | Non Formulary | ||||
| Endocrine system / Acromegaly | |||||
| octreotide | Restricted | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | Restricted | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| Endocrine system / Diabetes mellitus | |||||
| acarbose | On Formulary | ||||
| alogliptin | Non Formulary | ||||
| biphasic insulin aspart | On Formulary | ||||
| Suspension for injection | |||||
| NovoMix 30 FlexPen (Novo Nordisk Ltd) | On Formulary | ||||
| NovoMix 30 Penfill (Novo Nordisk Ltd) | On Formulary | ||||
| biphasic insulin lispro | Restricted | ||||
| Suspension for injection | |||||
| Humalog Mix25 (Eli Lilly and Company Ltd) | Restricted | ||||
| Humalog Mix25 KwikPen (Eli Lilly and Company Ltd) | Restricted | ||||
| Humalog Mix50 (Eli Lilly and Company Ltd) | Restricted | ||||
| Humalog Mix50 KwikPen (Eli Lilly and Company Ltd) | Restricted | ||||
| biphasic isophane insulin | On Formulary | ||||
| Suspension for injection | |||||
| Humulin M3 (Eli Lilly and Company Ltd) | On Formulary | ||||
| Humulin M3 KwikPen (Eli Lilly and Company Ltd) | On Formulary | ||||
| Hypurin Porcine 30/70 Mix (Wockhardt UK Ltd) | Non Formulary | ||||
| canagliflozin | On Formulary |
NICE TA390 NICE TA315 |
|||
| dapagliflozin | On Formulary |
NICE TA288 NICE TA390 NICE TA418 NICE TA679 NICE TA902 NICE TA775 |
|||
|
DAPAGLIFLOZIN
Type 2 diabetes as per: NICE TA288, NICE TA390 and NICE TA418
It is no longer licensed for use in type 1 diabetes as per MHRA Drug Safety Update (December 2021)- https://www.gov.uk/drug-safety-update/dapagliflozin-forxiga-no-longer-authorised-for-treatment-of-type-1-diabetes-mellitus
Heart Failure- for use as per TA679, initiation in Secondary Care and primary care continuation after 1 month
|
|||||
| dulaglutide | On Formulary | ||||
| Solution for injection | |||||
| Trulicity (Eli Lilly and Company Ltd) | On Formulary | ||||
| empagliflozin | On Formulary |
NICE TA390 NICE TA336 NICE TA773 NICE TA929 NICE TA942 |
|||
| ertugliflozin | On Formulary |
NICE TA572 NICE TA583 |
|||
|
Note
On formulary as per NICE TA572 and TA583. (CPC November 2019) |
|||||
| exenatide | Non Formulary | ||||
| gliclazide | On Formulary | ||||
| Modified-release tablet | |||||
| Gliclazide (Non-proprietary) | On Formulary | ||||
| Diamicron MR (Servier Laboratories Ltd) | Non Formulary | ||||
| Edicil MR (Teva UK Ltd) | Non Formulary | ||||
| Ziclaseg (Lupin Healthcare (UK) Ltd) | Non Formulary | ||||
| glimepiride | Non Formulary | ||||
| glipizide | On Formulary | ||||
| insulin | On Formulary |
NICE TA151 NICE TA943 |
|||
| Solution for injection | |||||
| Insulin (Non-proprietary) | On Formulary | ||||
| Actrapid (Novo Nordisk Ltd) | On Formulary | ||||
| Humulin S (Eli Lilly and Company Ltd) | On Formulary | ||||
| Hypurin Porcine Neutral (Wockhardt UK Ltd) | Restricted | ||||
| insulin aspart | On Formulary |
NICE TA151 |
|||
| Solution for injection | |||||
| Fiasp (Novo Nordisk Ltd) | On Formulary | ||||
| Fiasp FlexTouch (Novo Nordisk Ltd) | Non Formulary | ||||
| Fiasp Penfill (Novo Nordisk Ltd) | Non Formulary | ||||
| NovoRapid (Novo Nordisk Ltd) | On Formulary | ||||
| NovoRapid FlexPen (Novo Nordisk Ltd) | On Formulary | ||||
| NovoRapid FlexTouch (Novo Nordisk Ltd) | Non Formulary | ||||
| NovoRapid Penfill (Novo Nordisk Ltd) | On Formulary | ||||
| NovoRapid PumpCart (Novo Nordisk Ltd) | Restricted | ||||
| insulin degludec | Restricted | ||||
| Solution for injection | |||||
| Tresiba FlexTouch (Novo Nordisk Ltd) | Restricted | ||||
| Tresiba Penfill (Novo Nordisk Ltd) | Restricted | ||||
| insulin degludec with liraglutide | |||||
| Solution for injection | |||||
| Xultophy (Novo Nordisk Ltd) | Non Formulary | ||||
| insulin detemir | Restricted | ||||
| Solution for injection | |||||
| Levemir FlexPen (Novo Nordisk Ltd) | Restricted | ||||
| Levemir Penfill (Novo Nordisk Ltd) | Restricted | ||||
| insulin glargine | On Formulary | ||||
| Solution for injection | |||||
| Abasaglar (Eli Lilly and Company Ltd) | On Formulary | ||||
| Abasaglar KwikPen (Eli Lilly and Company Ltd) | On Formulary | ||||
| Toujeo (Sanofi) | Restricted | ||||
| insulin glulisine | Restricted |
NICE TA151 |
|||
| Solution for injection | |||||
| Apidra (Sanofi) | Restricted | ||||
| Apidra SoloStar (Sanofi) | Restricted | ||||
| insulin lispro | On Formulary |
NICE TA151 |
|||
| Solution for injection | |||||
| Humalog (Eli Lilly and Company Ltd) | On Formulary | ||||
| Humalog KwikPen (Eli Lilly and Company Ltd) | On Formulary | ||||
| isophane insulin | On Formulary | ||||
| Suspension for injection | |||||
| Humulin I (Eli Lilly and Company Ltd) | On Formulary | ||||
| Humulin I KwikPen (Eli Lilly and Company Ltd) | On Formulary | ||||
| Hypurin Porcine Isophane (Wockhardt UK Ltd) | Non Formulary | ||||
| Insulatard (Novo Nordisk Ltd) | On Formulary | ||||
| Insulatard Penfill (Novo Nordisk Ltd) | On Formulary | ||||
| linagliptin | Restricted | ||||
| liraglutide | On Formulary |
NICE TA664 |
|||
| Solution for injection | |||||
| Saxenda (Novo Nordisk Ltd) | Non Formulary | ||||
| Victoza (Novo Nordisk Ltd) | On Formulary | ||||
| lixisenatide | On Formulary | ||||
| metformin hydrochloride | On Formulary | ||||
| Modified-release tablet | |||||
| Metformin hydrochloride (Non-proprietary) | On Formulary | ||||
| Diagemet XL (Genus Pharmaceuticals Ltd) | Non Formulary | ||||
| Glucient SR (Consilient Health Ltd) | Non Formulary | ||||
| Glucophage SR (Merck Serono Ltd) | Non Formulary | ||||
| Meijumet (Medreich Plc) | Non Formulary | ||||
| Metabet SR (Morningside Healthcare Ltd) | Non Formulary | ||||
| Sukkarto SR (Morningside Healthcare Ltd) | Non Formulary | ||||
| Oral solution | |||||
| Metformin hydrochloride (Non-proprietary) | On Formulary | ||||
| pioglitazone | Restricted | ||||
| repaglinide | Non Formulary | ||||
| saxagliptin | Restricted | ||||
| semaglutide | Restricted |
NICE TA875 |
|||
| sitagliptin | On Formulary | ||||
| sitagliptin with metformin | Non Formulary | ||||
| tolbutamide | On Formulary | ||||
| vildagliptin | Non Formulary | ||||
| vildagliptin with metformin | Non Formulary | ||||
| Endocrine system / Diabetic nephropathy | |||||
| captopril | On Formulary | ||||
| irbesartan | Restricted | ||||
| lisinopril | On Formulary | ||||
| Oral solution | |||||
| Lisinopril (Non-proprietary) | Non Formulary | ||||
| losartan potassium | Restricted | ||||
| Endocrine system / Diabetes, diagnosis and monitoring | |||||
| glucose | On Formulary | ||||
| Oral solution | |||||
| Rapilose OGTT (Penlan Healthcare Ltd) | On Formulary | ||||
| Oral gel | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Dextrogel (Neoceuticals Ltd) | On Formulary | ||||
| GlucoBoost (Ennogen Healthcare International Ltd) | On Formulary | ||||
| GlucoGel (BBI Healthcare Ltd) | On Formulary | ||||
| Rapilose (Penlan Healthcare Ltd) | On Formulary | ||||
| Infusion | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Endocrine system / Diabetic neuropathy | |||||
| capsaicin | Restricted | ||||
| carbamazepine | On Formulary | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | On Formulary | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | On Formulary | ||||
| duloxetine | Restricted | ||||
| Gastro-resistant capsule | |||||
| Duloxetine (Non-proprietary) | Restricted | ||||
| Cymbalta (Eli Lilly and Company Ltd) | Non Formulary | ||||
| Duciltia (Pharmathen S.A.) | Non Formulary | ||||
| Yentreve (Eli Lilly and Company Ltd) | Restricted | ||||
| Endocrine system / Hypoglycaemia | |||||
| glucagon | On Formulary | ||||
| Powder and solvent for solution for injection | |||||
| GlucaGen Hypokit (Novo Nordisk Ltd) | On Formulary | ||||
| glucose | On Formulary | ||||
| Oral solution | |||||
| Rapilose OGTT (Penlan Healthcare Ltd) | Non Formulary | ||||
| Oral gel | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Dextrogel (Neoceuticals Ltd) | On Formulary | ||||
| GlucoBoost (Ennogen Healthcare International Ltd) | On Formulary | ||||
| GlucoGel (BBI Healthcare Ltd) | On Formulary | ||||
| Rapilose (Penlan Healthcare Ltd) | On Formulary | ||||
| Infusion | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Glucose (Non-proprietary) | On Formulary | ||||
| Endocrine system / Chronic hypoglycaemia | |||||
| diazoxide | On Formulary | ||||
| Endocrine system / Corticosteroid responsive conditions | |||||
| betamethasone | On Formulary | ||||
| Solution for injection | |||||
| Betamethasone (Non-proprietary) | Restricted | ||||
| deflazacort | Non Formulary | ||||
| dexamethasone | On Formulary |
NICE TA229 NICE TA824 NICE TA460 |
|||
| Oral solution | |||||
| Dexamethasone (Non-proprietary) | Restricted | ||||
| Dexsol (Rosemont Pharmaceuticals Ltd) | Non Formulary | ||||
| Solution for injection | |||||
| Dexamethasone (Non-proprietary) | On Formulary | ||||
| Eye drops | |||||
| Dexamethasone (Non-proprietary) | On Formulary | ||||
| Dexafree (Thea Pharmaceuticals Ltd) | On Formulary | ||||
| Dropodex (Rayner Pharmaceuticals Ltd) | On Formulary | ||||
| Maxidex (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| fludrocortisone acetate | On Formulary | ||||
| hydrocortisone | On Formulary | ||||
| Muco-adhesive buccal tablet | |||||
| Hydrocortisone (Non-proprietary) | Non Formulary | ||||
| Modified-release tablet | |||||
| Plenadren (Takeda UK Ltd) | Non Formulary | ||||
| Solution for injection | |||||
| Hydrocortisone (Non-proprietary) | On Formulary | ||||
| Powder for solution for injection | |||||
| Solu-Cortef (Pfizer Ltd) | On Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Solu-Cortef (Pfizer Ltd) | On Formulary | ||||
| methylprednisolone | On Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Solu-Medrone (Pfizer Ltd) | On Formulary | ||||
| Suspension for injection | |||||
| Depo-Medrone (Pfizer Ltd) | On Formulary | ||||
| prednisolone | On Formulary | ||||
| Gastro-resistant tablet | |||||
| Prednisolone (Non-proprietary) | Non Formulary | ||||
| Dilacort (Crescent Pharma Ltd) | Non Formulary | ||||
| Oral solution | |||||
| Prednisolone (Non-proprietary) | Non Formulary | ||||
| Eye drops | |||||
| Prednisolone (Non-proprietary) | On Formulary | ||||
| Pred Forte (AbbVie Ltd) | On Formulary | ||||
| Suppository | |||||
| Prednisolone (Non-proprietary) | Restricted | ||||
| triamcinolone acetonide | Restricted | ||||
| Suspension for injection | |||||
| Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | Restricted | ||||
| Spray | |||||
| Nasacort (Sanofi Consumer Healthcare) | Non Formulary | ||||
| Endocrine system / Cushing's syndrome and disease | |||||
| ketoconazole | Non Formulary | ||||
| metyrapone | On Formulary | ||||
| Endocrine system / Female sex hormone responsive conditions | |||||
| clonidine hydrochloride | On Formulary | ||||
| conjugated oestrogens (equine) | Restricted | ||||
| conjugated oestrogens with medroxyprogesterone | On Formulary | ||||
| Modified-release tablet | |||||
| Premique (Pfizer Ltd) | On Formulary | ||||
| estradiol | On Formulary | ||||
| Transdermal patch | |||||
| Estraderm MX (Norgine Pharmaceuticals Ltd) | On Formulary | ||||
| Estradot (Sandoz Ltd) | On Formulary | ||||
| Evorel (Theramex HQ UK Ltd) | On Formulary | ||||
| FemSeven (Theramex HQ UK Ltd) | On Formulary | ||||
| Progynova TS (Bayer Plc) | On Formulary | ||||
| Spray | |||||
| Lenzetto (Gedeon Richter (UK) Ltd) | Restricted | ||||
| estradiol with dydrogesterone | On Formulary | ||||
| Form unstated | |||||
| Femoston 1/10 (Exeltis UK Ltd) | On Formulary | ||||
| Femoston 2/10 (Exeltis UK Ltd) | On Formulary | ||||
| estradiol with levonorgestrel | |||||
| Transdermal patch | |||||
| FemSeven Conti (Theramex HQ UK Ltd) | On Formulary | ||||
| estradiol with medroxyprogesterone | |||||
| Form unstated | |||||
| Tridestra (Orion Pharma (UK) Ltd) | On Formulary | ||||
| estradiol with norethisterone | On Formulary | ||||
| Transdermal patch | |||||
| Evorel Conti (Theramex HQ UK Ltd) | On Formulary | ||||
| Form unstated | |||||
| Elleste Duet (Exeltis UK Ltd) | On Formulary | ||||
| Novofem (Novo Nordisk Ltd) | On Formulary | ||||
| Trisequens (Novo Nordisk Ltd) | On Formulary | ||||
| ethinylestradiol | On Formulary | ||||
| medroxyprogesterone acetate | On Formulary | ||||
| Suspension for injection | |||||
| Depo-Provera (Pfizer Ltd) | Non Formulary | ||||
| Sayana Press (Pfizer Ltd) | Non Formulary | ||||
| norethisterone | On Formulary | ||||
| Solution for injection | |||||
| Noristerat (Bayer Plc) | Non Formulary | ||||
| progesterone | Restricted | ||||
| Solution for injection | |||||
| Progesterone (Non-proprietary) | Non Formulary | ||||
| Vaginal gel | |||||
| Crinone (Merck Serono Ltd) | Non Formulary | ||||
| raloxifene hydrochloride | Restricted |
NICE TA160 NICE TA161 |
|||
| tibolone | On Formulary | ||||
| Endocrine system / Anti-oestrogens | |||||
| clomifene citrate | On Formulary | ||||
| Endocrine system / Male sex hormone responsive conditions | |||||
| testosterone | Restricted | ||||
|
Note
Testosterone (Gel sachets (Testogel®) & gel pump (Tostran®) approved in March 2022 JFC for use as Hormone Replacement Therapy (unlicensed). Hospital Only |
|||||
| testosterone decanoate, isocaproate, phenylpropionate and propionate | Restricted | ||||
| Endocrine system / Male sex hormone antagonism | |||||
| cyproterone acetate | On Formulary | ||||
| Endocrine system / Dopamine responsive conditions | |||||
| bromocriptine | On Formulary | ||||
| cabergoline | On Formulary | ||||
| quinagolide | Restricted | ||||
| Form unstated | |||||
| Quinagolide (Non-proprietary) | Restricted | ||||
| Endocrine system / Bone metabolism disorders | |||||
| alendronic acid | On Formulary |
NICE TA464 |
|||
| Oral solution | |||||
| Alendronic acid (Non-proprietary) | Restricted | ||||
| alendronic acid with colecalciferol | Non Formulary | ||||
| calcitonin (salmon) | On Formulary | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | On Formulary | ||||
| calcitriol | Non Formulary | ||||
| Oral solution | |||||
| Calcitriol (Non-proprietary) | Non Formulary | ||||
| denosumab | On Formulary |
NICE TA204 NICE TA265 |
|||
|
DENOSUMAB
Recommended following NICE TA 204 Added to the CHS formulary for use in men with osteoprosis folowing SWL formulary harmonisation |
|||||
| Solution for injection | |||||
| Prolia (Amgen Ltd) | On Formulary | ||||
| Xgeva (Amgen Ltd) | Non Formulary | ||||
| ibandronic acid | Non Formulary |
NICE TA464 |
|||
| Solution for injection | |||||
| Ibandronic acid (Non-proprietary) | Non Formulary | ||||
| Bonviva (Atnahs Pharma UK Ltd) | Non Formulary | ||||
| Solution for infusion | |||||
| Ibandronic acid (Non-proprietary) | Non Formulary | ||||
| Bondronat (Atnahs Pharma UK Ltd) | Non Formulary | ||||
| pamidronate disodium | On Formulary | ||||
| Solution for infusion | |||||
| Pamidronate disodium (Non-proprietary) | On Formulary | ||||
| raloxifene hydrochloride | Restricted |
NICE TA160 NICE TA161 |
|||
| risedronate sodium | Restricted |
NICE TA464 |
|||
| sodium clodronate | On Formulary | ||||
| teriparatide | Restricted |
NICE TA161 |
|||
| Solution for injection | |||||
| Forsteo (Eli Lilly and Company Ltd) | Restricted | ||||
| zoledronic acid | On Formulary |
NICE TA464 |
|||
| Infusion | |||||
| Aclasta (Sandoz Ltd) | Non Formulary | ||||
| Zometa (Phoenix Labs Ltd) | Non Formulary | ||||
| Solution for infusion | |||||
| Zoledronic acid (Non-proprietary) | On Formulary | ||||
| Zometa (Phoenix Labs Ltd) | Non Formulary | ||||
| Endocrine system / Diabetes insipidus | |||||
| chlortalidone | Non Formulary | ||||
| desmopressin | On Formulary | ||||
| Oral lyophilisate | |||||
| DesmoMelt (Ferring Pharmaceuticals Ltd) | Non Formulary | ||||
| Noqdirna (Ferring Pharmaceuticals Ltd) | Non Formulary | ||||
| Solution for injection | |||||
| Octim (Ferring Pharmaceuticals Ltd) | Non Formulary | ||||
| Spray | |||||
| Desmopressin (Non-proprietary) | Non Formulary | ||||
| Desmospray (Imported (Germany)) | Non Formulary | ||||
| vasopressin | On Formulary | ||||
| Solution for injection | |||||
| Vasopressin (Non-proprietary) | On Formulary | ||||
| Endocrine system / Syndrome of inappropriate antidiuretic hormone secretion | |||||
| demeclocycline hydrochloride | On Formulary | ||||
| tolvaptan | Restricted |
NICE TA358 |
|||
| Endocrine system / Thyroid disorders | |||||
| thyrotropin alfa | Non Formulary | ||||
| Powder for solution for injection | |||||
| Thyrogen (Sanofi) | Non Formulary | ||||
| Endocrine system / Hyperthyroidism | |||||
| carbimazole | On Formulary | ||||
| iodide with iodine | On Formulary | ||||
| metoprolol tartrate | On Formulary | ||||
| Solution for injection | |||||
| Betaloc (Recordati Pharmaceuticals Ltd) | Non Formulary | ||||
| nadolol | Non Formulary | ||||
| propranolol hydrochloride | On Formulary | ||||
| Modified-release capsule | |||||
| Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Non Formulary | ||||
| Beta-Prograne (Accord-UK Ltd) | Non Formulary | ||||
| Half Beta-Prograne (Accord-UK Ltd) | Non Formulary | ||||
| Oral solution | |||||
| Propranolol hydrochloride (Non-proprietary) | Restricted | ||||
| propylthiouracil | On Formulary | ||||
| Endocrine system / Hypothyroidism | |||||
| levothyroxine sodium | On Formulary | ||||
| Oral solution | |||||
| Levothyroxine sodium (Non-proprietary) | Non Formulary | ||||
| liothyronine sodium | Non Formulary | ||||
| Powder for solution for injection | |||||
| Liothyronine sodium (Non-proprietary) | Non Formulary | ||||
| Endocrine system / Gonadotrophin responsive conditions | |||||
| buserelin | Restricted | ||||
| Solution for injection | |||||
| Suprefact (Neon Healthcare Ltd) | Non Formulary | ||||
| Spray | |||||
| Suprecur (Neon Healthcare Ltd) | Non Formulary | ||||
| cetrorelix | Non Formulary | ||||
| Powder and solvent for solution for injection | |||||
| Cetrotide (Merck Serono Ltd) | Non Formulary | ||||
| ganirelix | Non Formulary | ||||
| goserelin | Restricted | ||||
|
Note
As per IMOC (June 2021)- AMBER 2 Specialist Initiation, stabilisation for 1-3 months (depending on product), then continuation in primary care under an individual management plan |
|||||
| leuprorelin acetate | On Formulary | ||||
| nafarelin | Non Formulary | ||||
| Spray | |||||
| Synarel (Pfizer Ltd) | Non Formulary | ||||
| triptorelin | Restricted | ||||
|
TRIPTORELIN
Decapeptyl SR brand only in formulary, and it is On formulary for: 1) Precocious puberty. It is also available for shared care in Croydon for precocious puberty. 2) Locally advanced and metastatic prostate cancer- AMBER 2 Specialist Initiation, stabilisation for 1-3 months (depending on product), then continuation in primary care under an individual management plan |
|||||
| Endocrine system / Breast pain (mastalgia) | |||||
| tamoxifen | On Formulary | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | Non Formulary | ||||